By Industry | By Industry Segment | By Services and Suppliers | By Location | By Hotbed | Profile Search

Company Profile


 

Spring Bank Pharmaceuticals, Inc. 

113 Cedar Street
Ste S-7
Milford  Massachusetts  01757  U.S.A.
Phone: 508-473-5993 Fax: n/a


SEARCH JOBS


Industry
Pharmaceutical

Segment
Pharmaceuticals





Company News
Spring Bank Pharmaceuticals, Inc. Provides Update On Its Next-Generation STING Platform And Announces Publication Of An Abstract At ASCO Related To Its Lead STING Agonist Candidate, SB 11285 6/7/2017 8:28:09 AM
Spring Bank Pharmaceuticals, Inc. Announces Top-Line Results From The Initial Cohort Of The Phase IIa Segment Of The ACHIEVE Trial, A Global Phase 2 Clinical Trial For Chronic Hepatitis B Virus (HBV) 5/24/2017 12:26:27 PM
Spring Bank Pharmaceuticals, Inc. To Host Conference Call To Discuss Top-Line Results From The Initial Cohort Of The Phase IIa Segment Of Its ACHIEVE Trial 5/23/2017 11:19:39 AM
Spring Bank Pharmaceuticals, Inc. Announces The Data Safety Monitoring Board Approves Dose Escalation Of SB 9200 For The Second Cohort Of The Phase IIa Segment Of The ACHIEVE Trial, A Global Phase II Clinical Trial For Chronic Hepatitis B Virus (HBV) 5/15/2017 8:07:40 AM
Spring Bank Pharmaceuticals, Inc. Provides Corporate Update And Reports First Quarter 2017 Financial And Operational Results 4/28/2017 8:54:32 AM
Spring Bank Pharmaceuticals, Inc. Provides Corporate Update And Reports 2016 Financial And Operational Results 2/15/2017 8:09:01 AM
Garrett Winslow Joins Spring Bank Pharmaceuticals, Inc. As Vice President Of Legal 1/4/2017 8:18:56 AM
Spring Bank Pharmaceuticals, Inc. And Arbutus Biopharma (ABUS) Announce Preclinical Collaboration In Study Of Chronic Hepatitis B 12/19/2016 12:52:43 PM
Spring Bank Pharmaceuticals, Inc. Announces Financing Of $15 Million 11/21/2016 10:51:28 AM
Spring Bank Pharmaceuticals, Inc. Presents Data On STING Agonist SB 11285 At The AACR Special Conference On Tumor Immunology And Immunotherapy 10/20/2016 8:14:58 AM
1234
//-->